We are honored to share today our success story with @Sensorion — a clinical-stage biotech company dedicated to developing groundbreaking therapies for hearing loss disorders. Sensorion, based in Montpellier, France, is at the forefront of gene therapy innovation, with a robust pipeline targeting genetic hearing loss.

A huge thank you to @Bernd SCHMIDT, CTO of Sensorion, for this testimonial:

“We have been working with INITS over a number of years now and have been impressed by the level of expertise across CMC, including process development, CDMO selection and the preparation of regulatory submissions and meetings with regulatory agencies.

INITS take a true partnering approach which makes it feel them being an extension of the team rather than a separate entity."

We are proud to support companies like Sensorion in their mission to transform patient lives.

#Biotech #GeneTherapy #HearingLoss #Partnership #CMC #RegulatoryAffairs